000305575 001__ 305575
000305575 005__ 20251031115652.0
000305575 0247_ $$2doi$$a10.1093/neuonc/noaf251
000305575 0247_ $$2pmid$$apmid:41159380
000305575 0247_ $$2ISSN$$a1522-8517
000305575 0247_ $$2ISSN$$a1523-5866
000305575 037__ $$aDKFZ-2025-02237
000305575 041__ $$aEnglish
000305575 082__ $$a610
000305575 1001_ $$aArora, Sonali$$b0
000305575 245__ $$aIntegrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biology.
000305575 260__ $$aOxford$$bOxford Univ. Press$$c2025
000305575 3367_ $$2DRIVER$$aarticle
000305575 3367_ $$2DataCite$$aOutput Types/Journal article
000305575 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1761833857_4133649
000305575 3367_ $$2BibTeX$$aARTICLE
000305575 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000305575 3367_ $$00$$2EndNote$$aJournal Article
000305575 500__ $$aepub
000305575 520__ $$aMedulloblastoma and ependymoma are common pediatric central nervous system tumors with significant molecular and clinical heterogeneity. While molecular subgrouping has enabled classification into molecular subtypes, the extent of heterogeneity within these subgroups remains poorly defined.We collected bulk RNA sequencing data from 888 medulloblastoma and 370 ependymoma tumors to establish a comprehensive reference landscape. After rigorous batch effect correction, normalization, and dimensionality reduction, we generated a unified landscape to explore gene expression, signaling pathways, RNA fusions, and copy number variations.Our transcriptional analysis revealed distinct clustering patterns, including two primary ependymoma compartments, EPN-E1 and EPN-E2, each with specific RNA fusions and molecular signatures. In medulloblastoma, we observed precise stratification of Group 3/4 tumors by subtype and in SHH tumors by patient age. We also identified subtype-specific pathways and gene fusions, enriched in each group.This transcriptomic landscape serves as a resource for biomarker discovery, diagnostic refinement, and prediction of tumor biology and outcome. By enabling projection of new patients' bulk RNA-seq data onto the reference map using nearest neighbor analysis, the framework supports accurate subtype classification. The landscape is publicly available via Oncoscape, an interactive platform for global exploration and application.
000305575 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000305575 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000305575 650_7 $$2Other$$aRNA-Seq
000305575 650_7 $$2Other$$acopy number
000305575 650_7 $$2Other$$agene fusions
000305575 650_7 $$2Other$$apathways
000305575 650_7 $$2Other$$asubtyping
000305575 7001_ $$aNuechterlein, Nicholas$$b1
000305575 7001_ $$aJensen, Matt$$b2
000305575 7001_ $$aGlatzer, Gregory$$b3
000305575 7001_ $$0P:(DE-He78)8aad075b17d93a5636a34942bdbd7ee6$$aSievers, Philipp$$b4$$udkfz
000305575 7001_ $$aVaradharajan, Srinidhi$$b5
000305575 7001_ $$0P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aKorshunov, Andrey$$b6$$udkfz
000305575 7001_ $$0P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aSahm, Felix$$b7$$udkfz
000305575 7001_ $$aMack, Stephen C$$b8
000305575 7001_ $$aTaylor, Michael D$$b9
000305575 7001_ $$aGujral, Taran$$b10
000305575 7001_ $$aHolland, Eric C$$b11
000305575 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noaf251$$gp. noaf251$$pnn$$tNeuro-Oncology$$vnn$$x1522-8517$$y2025
000305575 909CO $$ooai:inrepo02.dkfz.de:305575$$pVDB
000305575 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8aad075b17d93a5636a34942bdbd7ee6$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000305575 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000305575 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000305575 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000305575 9141_ $$y2025
000305575 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-11$$wger
000305575 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2022$$d2024-12-11
000305575 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-11
000305575 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-11
000305575 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-11
000305575 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-11
000305575 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-11
000305575 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-11
000305575 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-11
000305575 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bNEURO-ONCOLOGY : 2022$$d2024-12-11
000305575 9201_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x0
000305575 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000305575 980__ $$ajournal
000305575 980__ $$aVDB
000305575 980__ $$aI:(DE-He78)B300-20160331
000305575 980__ $$aI:(DE-He78)HD01-20160331
000305575 980__ $$aUNRESTRICTED